{
    "title": "Italy's Alfasigma to buy US liver disease drugmaker Intercept for nearly $800 mln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12562039/Italys-Alfasigma-buy-drugmaker-Intercept-nearly-800-mln.html",
    "date": "2023-09-26",
    "keywords": [
        "intercept",
        "drug",
        "treatment",
        "portfolio",
        "year",
        "tuesday",
        "liver",
        "acquisition",
        "disease",
        "deal",
        "drugmaker",
        "system",
        "bolster",
        "presence",
        "allcash",
        "cholangitis",
        "ocaliva",
        "cost",
        "sense",
        "company",
        "market",
        "scale",
        "biotech",
        "analyst",
        "michael",
        "race",
        "steatohepatitis",
        "health",
        "regulator",
        "june",
        "onethird",
        "workforce",
        "focus",
        "share",
        "premium",
        "closing",
        "price",
        "stock",
        "morning",
        "trading",
        "peak",
        "end",
        "alfasigma",
        "prescription",
        "overthecounter",
        "dicloreum",
        "yovis",
        "reporting",
        "pratik",
        "jain",
        "bengaluru",
        "editing",
        "shilpi",
        "majumdar"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}